Exosome Diagnostics (Bio-Techne)

Exosome Diagnostics, under the mdxhealth brand, provides personalized molecular diagnostic solutions for early detection and risk stratification of aggressive prostate cancer and urologic diseases. Their assays, including Confirm mdx and GPS mdx, help improve biopsy accuracy and guide treatment decisions, impacting over 500,000 patients worldwide.